Line Farah
Papers
1
Total Citations
7
H-Index
1
About
Line Farah is a health economist and outcomes researcher whose work focuses on the economic evaluation of advanced oncological technologies, with a particular emphasis on prostate cancer treatment. Her research bridges the gap between clinical innovation and healthcare policy by rigorously assessing the cost-effectiveness of robotic surgical interventions. In her most-cited work, a 2022 cost-utility analysis, Farah compared robot-assisted radical prostatectomies (rRP) with robotic stereotactic body radiotherapy (rSBRT) for prostate cancer—the most common malignancy among men in France. This study provided critical insights into the comparative economic and clinical impacts of these two cutting-edge approaches, informing resource allocation in oncology. While her citation count is still growing, her contributions are notable for their direct relevance to healthcare decision-making, offering a framework for evaluating high-cost robotic technologies. Farah’s work exemplifies how health economics can guide personalized treatment pathways, ensuring that technological advancements translate into both clinical benefit and sustainable healthcare spending.
Research Focus
Key Achievements
Top Papers
- 1